Wizza, I suspect the damage is done early... And Ph2 trial would be set to determine Dosing Range and frequency...
When a drug is approved it also comes with those guidelines...
Larry Glass would probably give a quick reply to this question.. Settle the question conclusively...
It's a pity we were not doing the concussion trial as first trial before TBI... Much quicker and cheaper..
12 months time we will know just how much NNZ2566 is worth... If it performs our market will get a big surprise...
I really can't see any reason this could attain a $10bn MC... IF the drug proves up..
I also feel very confident FX and TBI will go really well.
The Case for Yes, page-22
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$22.14 |
Change
1.150(5.48%) |
Mkt cap ! $2.829B | |||
| Open | High | Low | Value | Volume |
| $21.50 | $22.44 | $21.50 | $13.15M | 598.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 437 | $22.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $22.15 | 8325 | 7 |
View Market Depth
| Last trade - 16.10pm 17/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |